Esophageal disease

Mar 20, 2020

Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan(TM) Esophageal Implant

Mar 03, 2020

Cernostics Announces Groundbreaking Data Demonstrating TissueCypher Performance for Predicting Risk of Progression to EAC in Patients With Non-Dysplastic BE

Oct 30, 2019

Biostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan(TM) Esophageal Implant for Treatment of Esophageal Conditions

Oct 22, 2019

TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences

May 09, 2019

CSA Medical's truFreeze® Spray Cryotherapy to be Featured During Digestive Disease Week® 2019

Feb 04, 2019

CSA Medical Announces First Patients in Oklahoma Treated with truFreeze® Spray Cryotherapy

Oct 04, 2018

Horizon Technology Finance Provides $15 Million Venture Loan Facility to CSA Medical

May 31, 2018

CSA Medical To Highlight RapidAV Catheter and Presentations of truFreeze Clinical Studies at DDW 2018

Feb 06, 2018

New Study Finds truFreeze® Spray Cryotherapy Less Painful than Radiofrequency Ablation for Treatment of Barrett's Esophagus Related Diseases

Nov 27, 2017

CSA Medical Announces Enrollment of First Patient into a Dedicated Esophageal Cancer Trial Using truFreeze® Rapid AV

Oct 12, 2017

Antacids Market Worth US $18.7 Billion by the End of 2025 Globally: Transparency Market Research